Anika Therapeutics Inc (NASDAQ:ANIK)

45.13
Delayed Data
As of Apr 20
 -0.40 / -0.88%
Today’s Change
42.51
Today|||52-Week Range
69.81
-16.29%
Year-to-Date
New Strong Sell Stocks for April 20th
Apr 20 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for April 16th
Apr 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close45.53
Today’s open45.34
Day’s range45.03 - 46.17
Volume88,851
Average volume (3 months)88,244
Market cap$786.0M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-1.86%
Earnings growth (this year)-20.41%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)+9.71%
P/E ratio21.4
Price/Sales7.16
Price/Book2.98

Competitors

 Today’s
change
Today’s
% change
ATRCAtriCure Inc-0.12-0.56%
LMNXLuminex Corp-0.02-0.09%
LMATLeMaitre Vascular In...-0.54-1.32%
XENTIntersect ENT Inc+0.20+0.48%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.31
Annual revenue (last year)$113.4M
Annual profit (last year)$31.8M
Net profit margin28.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Joseph G. Darling
Chief Financial Officer, Secretary &
Treasurer
Sylvia Cheung
Corporate headquarters
Bedford, Massachusetts

Forecasts